Recent advances in nanopore sequencing
- PMID: 23138639
- PMCID: PMC3804109
- DOI: 10.1002/elps.201200272
Recent advances in nanopore sequencing
Abstract
The prospect of nanopores as a next-generation sequencing platform has been a topic of growing interest and considerable government-sponsored research for more than a decade. Oxford Nanopore Technologies recently announced the first commercial nanopore sequencing devices, to be made available by the end of 2012, while other companies (Life, Roche, and IBM) are also pursuing nanopore sequencing approaches. In this paper, the state of the art in nanopore sequencing is reviewed, focusing on the most recent contributions that have or promise to have next-generation sequencing commercial potential. We consider also the scalability of the circuitry to support multichannel arrays of nanopores in future sequencing devices, which is critical to commercial viability.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Figures
References
-
- Feero WG, Guttmacher AE, Collins FS. New England Journal of Medicine. 2010;362(21):2001–2011. - PubMed
-
- Pennisi E. Science. 2012;336(6081):534–537. - PubMed
-
- Hamermesh RG, Aspinall M, A P. Technical Report N9-812-004. Harvard Business School; Oct, 2011. Gene sequencing: Staking a position in an expanding industry.
-
- Branton D, Deamer DW, Marziali A, Bayley H, Benner SA, Butler T, Ventra MD, Garaj S, Hibbs A, Huang X, Jovanovich SB, Krstic PS, Lindsay S, Ling XS, Mastrangelo CH, Meller A, Oliver JS, Pershin YV, Ramsey JM, Riehn R, Soni GV, Tabard-Cossa V, Wanunu M, Wiggin M, Schloss JA. Nat Biotechnol. 2008 Sep;26(10):1–8. - PMC - PubMed
-
- Schloss J. Nat Biotechnol. 2008;26:1113. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
